Inflammatory peptides at the beginning of hemodialysis in asymptomatic patients treated or not with angiotensin I-converting inhibitors.
Marceau, F
Inflammatory peptides at the beginning of hemodialysis in asymptomatic patients treated or not with angiotensin I-converting inhibitors. [electronic resource] - Nephron 1995 - 474-6 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Letter; Research Support, Non-U.S. Gov't
1660-8151
10.1159/000188776 doi
Anaphylatoxins--analysis
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Bradykinin--blood
Complement C3a--analysis
Complement C5a--analysis
Female
Humans
Male
Middle Aged
Renal Dialysis
Inflammatory peptides at the beginning of hemodialysis in asymptomatic patients treated or not with angiotensin I-converting inhibitors. [electronic resource] - Nephron 1995 - 474-6 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Letter; Research Support, Non-U.S. Gov't
1660-8151
10.1159/000188776 doi
Anaphylatoxins--analysis
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Bradykinin--blood
Complement C3a--analysis
Complement C5a--analysis
Female
Humans
Male
Middle Aged
Renal Dialysis